Autolus Therapeutics PLC

The current institutional shareholding score of Autolus Therapeutics PLC is 7.00, ranking 80 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 78.88%, representing a quarter-over-quarter decrease of 12.89%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.86% of shares outstanding, with 0.46% decrease in holdings.